M.N.Eye Hospital Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 15-11-2024
- Paid Up Capital ₹ 8.12 M
as on 15-11-2024
- Company Age 14 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.00 Cr
as on 15-11-2024
- Revenue 24.64%
(FY 2023)
- Profit -29.13%
(FY 2023)
- Ebitda -12.73%
(FY 2023)
- Net Worth 11.66%
(FY 2023)
- Total Assets -7.65%
(FY 2023)
About M.N.Eye Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 8.12 M.
The company currently has active open charges totaling ₹4.00 Cr.
Madhivanan Natarajan, Chalini Madhivanan, Nivean Natarajan, and Three other members serve as directors at the Company.
- CIN/LLPIN
U85100TN2010PTC077225
- Company No.
077225
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Sep 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at M.N.Eye Hospital?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chalini Madhivanan  | Managing Director | 03-Sep-2010 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Madhivanan Natarajan | Director | 03-Sep-2010 | Current |
| Nivean Natarajan | Director | 03-Sep-2010 | Current |
| Pratheeba Nivean | Director | 14-Apr-2016 | Current |
| Nishanth Madhivanan | Director | 03-Sep-2010 | Current |
| Shruti Nishanth | Director | 14-Apr-2016 | Current |
Financial Performance of M.N.Eye Hospital.
M.N.Eye Hospital Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 24.64% increase. The company also saw a substantial fall in profitability, with a 29.13% decrease in profit. The company's net worth Soared by an impressive increase of 11.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of M.N.Eye Hospital?
In 2023, M.N.Eye Hospital had a promoter holding of 90.00% and a public holding of 10.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Tamilnad Mercantile Bank Limited Creation Date: 22 Aug 2024 | ₹4.00 Cr | Open |
How Many Employees Work at M.N.Eye Hospital?
M.N.Eye Hospital has a workforce of 39 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of M.N.Eye Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped M.N.Eye Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
